Auto-generated: February 12 2012 06:49 PM GMT-8

205
Stars
Star This?

Source: DGNews  |  Posted 8 years ago

Thalomid Plus Temozolomide Promising As Oral Regimen For Treating Patients With Advanced-Stage Metastatic Melanoma

    Tags:

Read/Add Comments | Email This | Print This

WARREN, NJ -- September 8, 2003 -- Celgene Corporation (Nasdaq: CELG) today announced the results of a clinical study using Thalomid

205
Stars
Star This?  Yes / No

  • Comments

    To post a comment, please sign in or register as a physician.
 

Terms of Use |  Privacy Policy

© All Content Copyright 1995 - 2012 Doctor's Guide Publishing Limited. All Rights Reserved.

Sign InSign In
inst val